Driehaus Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Driehaus Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306M	Buy	949,225 +16,164	+2%	+$5M	2.25%	2
2025 Q4	$275M	Buy	933,061 +432,510	+86%	+$80.5M	1.87%	3
2025 Q3	$26.5M	Sell	500,551 -30,437	-6%	-$1.48M	0.19%	175
2025 Q2	$22.3M	Buy	530,988 +49,390	+10%	+$1.88M	0.18%	165
2025 Q1	$18.2M	Buy	481,598 +316,686	+192%	+$19.8M	0.18%	171
2024 Q4	$12.7M	Sell	164,912 -1,144	-0.7%	-$82.8K	0.1%	220
2024 Q3	$9.55M	Sell	166,056 -98,632	-37%	-$5.33M	0.08%	235
2024 Q2	$10.9M	Sell	264,688 -1,808	-0.7%	-$85.4K	0.11%	208
2024 Q1	$16.3M	Buy	+266,496	New	+$12M	0.16%	186

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Driehaus Capital Management's PRAX Position: Q1 2026 in Review

Driehaus Capital Management increased its Praxis Precision Medicines (PRAX) stake by 1.7% in Q1 2026, buying an estimated $5M and bringing the position to 949,225 shares worth $306M. The position accounts for 2.25% of the portfolio, ranked #2.

Driehaus Capital Management first reported a position in PRAX in Q1 2024 and has held it in 9 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Driehaus Capital Management held 949,225 shares of Praxis Precision Medicines worth $306M as of Q1 2026.
Driehaus Capital Management bought 16,164 Praxis Precision Medicines shares in Q1 2026, an estimated $5M.
Praxis Precision Medicines made up 2.25% of Driehaus Capital Management's portfolio in Q1 2026, its #2 holding.
Driehaus Capital Management first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 9 quarters since.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.